Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model

In vitro and descriptive studies of human tissue samples revealed the pro-coagulant glycoprotein tissue factor (TF) as a potent player in glioma cell infiltration that is activated by hypoxia and has also been shown to be upregulated by mutations of TP53 or PTEN. Here we present the morphological an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Harter, Patrick Nikolaus (VerfasserIn) , Capper, David (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 5 February 2013
In: Neuropathology
Year: 2013, Jahrgang: 33, Heft: 5, Pages: 515-525
ISSN:1440-1789
DOI:https://doi.org/10.1111/neup.12018
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/https://doi.org/10.1111/neup.12018
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/neup.12018
Volltext
Verfasserangaben:Patrick N. Harter, Stephan Dützmann, Ulrich Drott, Cornelia Zachskorn, Elke Hattingen, David Capper, Florian Gessler, Christian Senft, Volker Seifert, Karl H. Plate, Donat Kögel and Michel Mittelbronn

MARC

LEADER 00000caa a2200000 c 4500
001 1749423006
003 DE-627
005 20220819121234.0
007 cr uuu---uuuuu
008 210225s2013 xx |||||o 00| ||eng c
024 7 |a 10.1111/neup.12018  |2 doi 
035 |a (DE-627)1749423006 
035 |a (DE-599)KXP1749423006 
035 |a (OCoLC)1341396130 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Harter, Patrick Nikolaus  |d 1980-  |e VerfasserIn  |0 (DE-588)136226558  |0 (DE-627)578113074  |0 (DE-576)300907435  |4 aut 
245 1 0 |a Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model  |c Patrick N. Harter, Stephan Dützmann, Ulrich Drott, Cornelia Zachskorn, Elke Hattingen, David Capper, Florian Gessler, Christian Senft, Volker Seifert, Karl H. Plate, Donat Kögel and Michel Mittelbronn 
264 1 |c 5 February 2013 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.02.2021 
520 |a In vitro and descriptive studies of human tissue samples revealed the pro-coagulant glycoprotein tissue factor (TF) as a potent player in glioma cell infiltration that is activated by hypoxia and has also been shown to be upregulated by mutations of TP53 or PTEN. Here we present the morphological and genetic characterization of a novel glioblastoma in vivo model and provide evidence that treatment with an antibody targeting TF leads to reduced glioma cell invasiveness. Therefore, we established a murine xenograft treatment model by transplanting the angiogenic and diffusely infiltrating human glioma cell line MZ-18 with endogenous TF expression into nude mice brains and treating these mice with an intracranial osmotic pump system continuously infusing a monoclonal antibody against TF (mAb TF9-10H10). The human MZ-18 cell line harbors two TP53 mutations resulting in a strong nuclear accumulation of p53, thereby facilitating the unambiguous identification of tumor cells in the xenograft model. Intracranial application of TF9-10H10 significantly reduced invasion of MZ-18 cells compared to mock-treated control animals. The extent of activated blood vessels was also reduced upon anti-TF treatment. Thus, targeting the TF pathway might be a promising treatment strategy for future glioblastoma therapies, by affecting both invading tumor cells and tumor vasculature. 
650 4 |a glioma 
650 4 |a invasion 
650 4 |a migration 
650 4 |a p53 
650 4 |a tissue factor 
700 1 |a Capper, David  |d 1979-  |e VerfasserIn  |0 (DE-588)133950751  |0 (DE-627)558829902  |0 (DE-576)300212402  |4 aut 
773 0 8 |i Enthalten in  |t Neuropathology  |d Oxford [u.a.] : Wiley-Blackwell, 1993  |g 33(2013), 5, Seite 515-525  |h Online-Ressource  |w (DE-627)320469115  |w (DE-600)2008290-3  |w (DE-576)091169577  |x 1440-1789  |7 nnas  |a Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model 
773 1 8 |g volume:33  |g year:2013  |g number:5  |g pages:515-525  |g extent:11  |a Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model 
856 4 0 |u https://doi.org/https://doi.org/10.1111/neup.12018  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/neup.12018  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210225 
993 |a Article 
994 |a 2013 
998 |g 133950751  |a Capper, David  |m 133950751:Capper, David  |d 910000  |d 912000  |e 910000PC133950751  |e 912000PC133950751  |k 0/910000/  |k 1/910000/912000/  |p 6 
999 |a KXP-PPN1749423006  |e 3874336239 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Patrick N. Harter, Stephan Dützmann, Ulrich Drott, Cornelia Zachskorn, Elke Hattingen, David Capper, Florian Gessler, Christian Senft, Volker Seifert, Karl H. Plate, Donat Kögel and Michel Mittelbronn"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"5 February 2013"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1111/neup.12018"],"eki":["1749423006"]},"recId":"1749423006","person":[{"given":"Patrick Nikolaus","role":"aut","family":"Harter","display":"Harter, Patrick Nikolaus"},{"role":"aut","family":"Capper","display":"Capper, David","given":"David"}],"language":["eng"],"note":["Gesehen am 26.02.2021"],"title":[{"title_sort":"Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model","title":"Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model"}],"physDesc":[{"extent":"11 S."}],"relHost":[{"part":{"extent":"11","year":"2013","pages":"515-525","issue":"5","text":"33(2013), 5, Seite 515-525","volume":"33"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Neuropathology","title_sort":"Neuropathology"}],"disp":"Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma modelNeuropathology","name":{"displayForm":["Japanese Society of Neuropathology"]},"origin":[{"dateIssuedKey":"1993","publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford [u.a.]","dateIssuedDisp":"1993-","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell"}],"recId":"320469115","id":{"doi":["10.1111/(ISSN)1440-1789"],"eki":["320469115"],"zdb":["2008290-3"],"issn":["1440-1789"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 13.10.04"],"pubHistory":["13.1993 -"],"language":["eng"]}]} 
SRT |a HARTERPATRANTITISSUE5201